Dengdi Hu
Ningbo, 315300, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Biological differences between normal and cancer-associated fibroblasts in breast cancer.
Journal: Heliyon
Published: June 07, 2023
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Journal: Frontiers in oncology
Published: February 21, 2022
Cancer-associated fibroblasts in breast cancer: Challenges and opportunities.
Journal: Cancer communications (London, England)
Published: November 11, 2021
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Journal: Frontiers in oncology
Published: April 20, 2021
Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient.
Journal: Frontiers in cell and developmental biology
Published: March 15, 2021
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer.
Journal: Journal of cellular and molecular medicine
Published: October 11, 2020
Regulation of tamoxifen sensitivity by the PLAC8/MAPK pathway axis is antagonized by curcumin-induced protein stability change.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: June 19, 2020
LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
Journal: Molecular medicine reports
Published: August 27, 2018
[Retracted] LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
Journal: Molecular medicine reports
Published: August 27, 2018
MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.
Journal: American journal of cancer research
Published: May 12, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026